Registered Nurse in Hanover Park, IL Accepting Medicare
5 Registered Nurse nurses found. Showing 1 - 5
 Ms. Adrienne Louise Macwalters, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4073 Bayside Dr, Hanover Park, IL 60133 Phone: 630-483-1517 |
Tisa Mathew, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5545 Cambridge Way, Hanover Park, IL 60133 Phone: 630-415-6510 |
Virginie Nyancho, RN Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1336 Court Leona, Hanover Park, IL 60133 Phone: 331-245-7799 |
Oluwashola Adebola Adeniji, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5660 Cambridge Way, Hanover Park, IL 60133 Phone: 773-430-2222 |
Adrianne Rachel Cacal, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1888 Saint Clair Ln, Hanover Park, IL 60133 Phone: 630-254-5914 |
News Archive
Ortho-McNeil terminates collaboration agreement with Arena on APD597 trial program
Arena Pharmaceuticals, Inc. announced today that, following the completion of a Phase 1 clinical trial program for APD597 (JNJ-38431055) under its collaboration with Arena, Ortho-McNeil-Janssen Pharmaceuticals, Inc., has decided not to advance APD597 and has notified Arena that it is terminating the collaboration, effective December 28, 2010.
Black neighborhoods, segregated cities found to have high levels of noise pollution
As the number of white residents in a neighborhood declines, noise rises. But noise pollution is inescapable in segregated cities, where noise pollution is worse for everyone, according to the first breakdown of noise exposure along racial, ethnic and socioeconomic lines in the United States.
A protein that plays key role in endometrial cancer growth discovered
The hormone estrogen plays many critical roles in men and women, in both healthy tissues and in cancer. In breast and gynecologic cancers, estrogen sends signals to tumors instructing the cancer cells to grow out of control.
Spectrum Pharmaceuticals acquires rights and IP for Renazorb
Spectrum Pharmaceuticals today announced that it has acquired 100% rights to RenaZorb (a family of compounds represented by SPI-014, also known as RZB-014), a lanthanum-based nanotechnology compound with potent and selective phosphate binding properties, for all human and non-human indications.
› Verified 9 days ago